Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with kaposi’s sarcoma

Dermatology

Volumn 194, Issue 3, 1997, Pages 234-237

  Plettenberg, A ^a   Van Dyk, U ^a   Stoehr, A ^b   Albrecht, H ^c   Stellbrink, H J ^c   Berger, J ^a   Meigel, W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c Internal Medicine Center   (Germany)

Author keywords

AIDS; Kaposi and rsquo; s sarcoma; Opportunistic infection

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CANDIDIASIS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; DOXORUBICIN; ESOPHAGITIS; ETOPOSIDE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SKIN NEOPLASMS; VINBLASTINE; VINCRISTINE;

EID: 0030913720     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246109     Document Type: Article

References (21)

1. Tappero JW. Connanl MA. Wolle SF, et al: Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993:28: 371-376.
2. Plettenberg A, Meigel W: Endemic Kaposi's sarcoma - Etiopathogenesis. epidemiology, clinical presentation and therapy. Allergologie 1994;7:295-302.
3. Krown SE: AIDS-assoeiated Kaposi's sarcoma: Pathogenesis, clinical course and treatment, AIDS 1988:2:71-80.
4. Lilcnbaum RC. Ratner I.: Systemic treatment of Kaposi's sarcoma: Current status and future directions. AIDS 1994:8:141-151.
5. Plettenberg A. Kern P. Klare A. etal: IIIV-as-sociated Kaposi's sarcoma treated with recombinant interferon alfa 2a - Long-term results: in Freund M. Link H. Welte K (eds): Cytokines in Hemopoiesis. Oncology and AIDS. Berlin. Springer. 1990. pp 631-637.
6. Gompels MM. Hill A. Jenkins P. et al: Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1992:6: 1175-1180.
7. Caumes E. Guermonprez G. Katlama C. et al: AIDS-associated mucocutaneous Kaposi's sarcoma treated with bleomycin. AIDS 1992; 6:1483-1487.
8. Gellmann EP. Iango D. Lane HC. et al: Combination chemotherapy of disseminated Kaposi’s sarcoma in patients with acquired immune deficiency syndrome. Am J Med 1987:82:456-462.
9. Laubenstein LJ. Kriegel RL. Odajnyk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin. bleomycin, and vinblastine. J Clin Oncol 1984:2:1115-1120.
10. Presant CA. Scolaro M, Kennedy P. et al: Liposomal daunorubiein treatment of HIV-associated Kaposi's sarcoma. Lancet 1993:341: 1242-1243.
11. Shepherd FA. Burkes RL. Paul KE. et al: A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. AIDS 1991:5:305-309.
12. Fischl MA. Krown SE. O'Boyle KP. et al: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Delie Syndr 1993:6:259-264.
13. Gill PS. Akil B. Coletti P. et al: Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 1989;87:557-561.
14. Gill PS: Phase l/ll trial of alfa-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi’s sarcoma. Semin Oncol 1991:18:53-57.
15. Stewart JS: Current approaches to the treatment of HIV-related Kaposi's sarcoma and lymphoma by chemotherapy. AIDS 1990:4: 217-221.
16. Volbcrding PA. Abrams DI. Conant M. et al: Vinblastin therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intent Med 1985;103:335-338.
17. Groopman JE: Neoplasma in the acquired immune deficiency syndrome: The multidisciplinary approach to treatment. Semin Oncol 1987:14:1-6.
18. Centers for Disease Control: Classification system for human T-lymphotropic virus type lll/lymphadenopathy-associated virus infections. MMWR 1986:35:334-339.
19. Krown SE. Metroka C. Wernz JC: Kaposi's sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation, response and staging criteria. J Clin Oncol 1989:7:1201-1207.
20. Nelson MR. Erskrine D. Hawkins DA. et al: Treatment with corticosteroids - A risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993:7:375-378.
21. Kaplan LD. Hopewell PC. Jaffe H. et al: Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Delie Syndr 1988:1: 23-30.